Publication | Closed Access

A randomized placebo-controlled trial of combined early intravenous captopril and recombinant tissue-type plasminogen activator therapy in acute myocardial infarction

ThrombosisCardiovascular DiseaseRandomized Placebo-controlled TrialCardiovascular PharmacologyCardiologyIntravenous CaptoprilPharmacotherapyPlatelet AntagonistMedicineAnticoagulantAtherosclerosisEmergency MedicineAcute Myocardial InfarctionMyocardial Infarction